Rinat Rotem‐Yehudar
- Immunology top 2%
- Oncology top 2%
- Molecular Biology
- Hematology top 2%
- Genetics
- Co-authors
- Arnon NaglerAbraham KnellerRaanan BergerMerav LeibaMaya Koren‐MichowitzAvichai ShimoniEmilia GalperinMia Horowitz
- Topics
- Cancer Immunotherapy and Biomarkers (12 papers)Immunotherapy and Immune Responses (8 papers)CAR-T cell therapy research (7 papers)
- Cited by
- ImmunologyOncologyHematology
- Journals
- Journal of Biological ChemistryThe Journal of Experimental MedicineJournal of Clinical Oncology
- Partner nations
- IsraelUnited States
In The Last Decade
Rinat Rotem‐Yehudar
20 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Immunology 1.3k
- Oncology 1.2k
- Molecular Biology 469
- Hematology 430
- Genetics 129
Countries citing papers authored by Rinat Rotem‐Yehudar
This map shows the geographic impact of Rinat Rotem‐Yehudar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rinat Rotem‐Yehudar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rinat Rotem‐Yehudar more than expected).
Fields of papers citing papers by Rinat Rotem‐Yehudar
This network shows the impact of papers produced by Rinat Rotem‐Yehudar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rinat Rotem‐Yehudar. The network helps show where Rinat Rotem‐Yehudar may publish in the future.
Co-authorship network of co-authors of Rinat Rotem‐Yehudar
This figure shows the co-authorship network connecting the top 25 collaborators of Rinat Rotem‐Yehudar. A scholar is included among the top collaborators of Rinat Rotem‐Yehudar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rinat Rotem‐Yehudar. Rinat Rotem‐Yehudar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 56 | |
| 2 | 1 | |
| 3 | 4 | |
| 4 | 237 | |
| 5 | 121 | |
| 6 | The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibodybreakdown → | 660 |
| 7 | 3 | |
| 8 | 8 | |
| 9 | 2 | |
| 10 | Abstract #2410: CT-011, a humanized monoclonal antibody, interacts with the PD-1 receptor and modulates survival and trafficking signals in effector/memory T lymphocytes | 1 |
| 11 | 2 | |
| 12 | 5 | |
| 13 | Phase I Safety and Pharmacokinetic Study of CT-011, a Humanized Antibody Interacting with PD-1, in Patients with Advanced Hematologic Malignanciesbreakdown → | 536 |
| 14 | 7 | |
| 15 | 70 | |
| 16 | 105 | |
| 17 | 83 | |
| 18 | 64 | |
| 19 | 12 | |
| 20 | 31 |
About Rinat Rotem‐Yehudar
Rinat Rotem‐Yehudar is a scholar working on Immunology, Oncology and Hematology, having authored 20 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), Immunotherapy and Immune Responses (8 papers) and CAR-T cell therapy research (7 papers). The work is most often cited by research in Immunology (1.3k citations), Oncology (1.2k citations) and Hematology (430 citations). Rinat Rotem‐Yehudar has collaborated with scholars based in Israel and United States. Frequent co-authors include Arnon Nagler, Abraham Kneller, Raanan Berger, Merav Leiba, Maya Koren‐Michowitz, Avichai Shimoni, Emilia Galperin, Mia Horowitz, Rachel Ehrlich and Michael A. Caligiuri. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.